Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › KV1.3 inhibitors and their medical application

KV1.3 inhibitors and their medical application

US Patent 10822345 · Granted Nov 3, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chro2022
IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chro2022
Kv1.3 inhibitors and their medical application2020
Kv1.3 inhibitors and their medical application2020
Kv1.3 inhibitors and their medical application2020
Kv1.3 inhibitors and their medical application2020
Kv1.3 inhibitors and their medical applications2019
Kv1.3 inhibitors and their medical applications2019
2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors2018
Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of can2017
Substituted bicyclic heterocyclic compounds as gamma secretase modulators2015
Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine deri2014